United States · FDA National Drug Code directory
Cladribine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-4791_34340d61-039c-2b08-23a6-e3a2389f10a2
- Product NDC
- 60505-4791
- Form
- TABLET
- Composition / generic term
- Cladribine
- Labeler
- Apotex Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251125
- Source listing expiry
- 20271231
Source-listed ingredients
- CLADRIBINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET in 1 CARTON (60505-4791-1) · 60505-4791-1
- 4 TABLET in 1 CARTON (60505-4791-4) · 60505-4791-4
- 5 TABLET in 1 CARTON (60505-4791-5) · 60505-4791-5
- 6 TABLET in 1 CARTON (60505-4791-6) · 60505-4791-6
- 7 TABLET in 1 CARTON (60505-4791-7) · 60505-4791-7
- 8 TABLET in 1 CARTON (60505-4791-8) · 60505-4791-8
- 9 TABLET in 1 CARTON (60505-4791-9) · 60505-4791-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →